# Tae Min Kim, M.D., Ph.D. – FDA Inspection, Dec 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/tae-min-kim-md-phd/5b01f199-5510-48c0-b796-1502e9666c59
Source feed: FDA_Inspections

> FDA inspection 1226038 of Tae Min Kim, M.D., Ph.D., December 15, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1226038
- Company Name: Tae Min Kim, M.D., Ph.D.
- Inspection Date: 2023-12-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1283432 - 2025-08-29

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/dawn-c-olenjack/b5a18d10-cd4b-405e-9016-8f5274a33000)

Company: https://www.keypedia.com/companies/tae-min-kim-md-phd/65edf818-9c47-4104-9173-571185503eff

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c